THURSDAY5:30 PM Welcome and Dinner

6:30 PM – 8:00 PM Movie – The Hungry Heart

FRIDAY7:30 AM Registration Opens

8:00 AM – 10:15 AM Waiver Training

• Welcome and Introduction: Review the Day and IBH Concept• Overview: Opioid Use Disorder Treatment with Buprenorphine/Naloxone• Patient Evaluation • Specialty Topics• Case Study #1

10:15 AM – 10:30 AM Break

10:30 AM - 12:00 PM Waiver Training, continued

• Medication-Assisted Treatment Clinical Application• Case Study #2• Urine Drug Testing• Case Study #3

12:00 PM – 12:30 PM Lunch and Networking

12:30 PM – 1:00 PM Waiver Training, continued • Overview of Clinical Tools• Completing the Notification of Intent Waiver Form

1:00 PM – 2:15 PM Special MAT Topic

2:15 PM – 2:30 PM Break

2:30 PM – 4:00 PM Expert Panel

4:00 PM – 4:30 PM IBH Implementation and Wrap-Up

WOLF POINT AGENDA

Dr. Nauts completed his undergraduate and medical education at the University of Michigan. Following completion of an internal medicine residency at the University of Michigan Affiliated Hospitals and subsequent Board Certification in Internal Medicine, he entered group practice in Bellingham, Washington, in 1974. In 1986, he developed a hospital-based addictions treatment program also in Washington state. He became active in the American Society of Addiction Medicine (ASAM), participating in the development of the ASAM Patient Placement Criteria which is widely used nationally. He remains active in practice guideline development regarding alcohol withdrawal management and screening in primary care settings. He was certified by ASAM in 1987.

In 1993 Dr. Nauts moved to Great Falls to assume directorship of Benefis Healthcare Addiction Medicine Services. Both in Washington state and Montana, he has been an active educator delivering presentations to audiences in addiction services, State Administration, managed care, third party payors, nurses, and physicians. He has been active in addressing physician and nurse health issues both in Washington and Montana. He is an active educator providing Addiction Medicine experience for residents of the Western Montana Family Practice Program and PA students from the University of Washington Medex Program.

At the forefront of developing flexible treatment strategies with focus on the application of Stage of Change Theory and Motivational Enhancement, he has had an integral role in developing co-occurring capable treatment programs in Great Falls, Montana State Hospital, and in Missoula through Western Montana Mental Health Center and Recovery Center Missoula. He is an avid advocate for integrated management of patients with the overlap of substance use disorders, mood and anxiety disorders, and chronic pain.

He currently serves as the medical director of Recovery Center Missoula, medical director of Integrated Medication Assisted Treatment (IMAT) a hub and spoke model funded by the State of Montana with a SAMHSA grant. He is a member of the Drug Utilization Board of Mountain Pacific Quality Health providing oversight to the Medicaid formulary. He recently was recognized as a Fellow of the American Society of Addiction Medicine (FASAM) and is certified in the subspecialty of Addiction Medicine by the American Board of Preventive Medicine. He was one of the first physicians in Montana to provide medication assisted treatment for opioid use disorders with buprenorphine.

He recently completed the 6th International Conference on Academic Detailing held at Harvard Medical School with the intent of developing a team to provide Academic Detailing to providers here in Montana. Academic detailing emphasizes effective communication of best evidence, providing critical tools to the front line of care. AD is an evidence-based intervention with excellent success in addressing problems in health care delivery. His initial focus is on increasing access to effective Medication Assisted Treatment (MAT) for Opioid Use Disorder (OUD) in Montana and is available to any provider(s) across Montana.

Daniel A. Nauts, M.D., FASAM

Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Medication Assisted Treatment (5U79TI024697) from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organization imply endorsement by the U.S. Government.

ACCME Accreditation Statement: The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement: The American Society of Addiction Medicine designates this enduring material for a maximum of 3.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Society of Addiction Medicine designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.